Cargando…

SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1

BACKGROUND: Grb2 (Growth factor receptor-bound protein 2) is a key adaptor protein in maintaining the ERK activity via linking Sos1 (Son of sevenless homolog 1) or other proteins to activated RTKs, such as EGFR. Currently, little knowledge is available concerning the post-translational modification...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yingying, Chen, Qin, Lai, Xueping, Zhu, Changhong, Chen, Cheng, Zhao, Xian, Deng, Rong, Xu, Ming, Yuan, Haihua, Wang, Yanli, Yu, Jianxiu, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021559/
https://www.ncbi.nlm.nih.gov/pubmed/24775912
http://dx.doi.org/10.1186/1476-4598-13-95
_version_ 1782316260180099072
author Qu, Yingying
Chen, Qin
Lai, Xueping
Zhu, Changhong
Chen, Cheng
Zhao, Xian
Deng, Rong
Xu, Ming
Yuan, Haihua
Wang, Yanli
Yu, Jianxiu
Huang, Jian
author_facet Qu, Yingying
Chen, Qin
Lai, Xueping
Zhu, Changhong
Chen, Cheng
Zhao, Xian
Deng, Rong
Xu, Ming
Yuan, Haihua
Wang, Yanli
Yu, Jianxiu
Huang, Jian
author_sort Qu, Yingying
collection PubMed
description BACKGROUND: Grb2 (Growth factor receptor-bound protein 2) is a key adaptor protein in maintaining the ERK activity via linking Sos1 (Son of sevenless homolog 1) or other proteins to activated RTKs, such as EGFR. Currently, little knowledge is available concerning the post-translational modification (PTM) of Grb2 except for its phosphorylation. Since emerging evidences have highlighted the importance of SUMOylation (Small ubiquitin-related modifier), a reversible PTM, in modulating protein functions, we wondered if Grb2 could be SUMOylated and thereby influences its functions especially involved in the Ras/MEK/ERK pathway. METHODS: SUMOylation of Grb2 was analyzed with the in vivo SUMOylation assay using the Ni(2+)-NTA affinity pulldown and the in vitro E.coli-based SUMOylation assay. To test the ERK activity and cell transformation, the murine fibroblast cell line NIH/3T3 and the murine colon cancer cell line CMT-93 were used for the experiments including Grb2 knockdown, ectopic re-expression, cell transformation and migration. Immunoprecipitation (IP) was employed for seeking proteins that interact with SUMO modified Grb2. Xenograft tumor model in mice was conducted to verify that Grb2 SUMOylation regulated tumorigenesis in vivo. RESULTS: Grb2 can be SUMOylated by SUMO1 at lysine 56 (K(56)), which is located in the linker region between the N-terminal SH3 domain and the SH2 domain. Knockdown of Grb2 reduced the ERK activity and suppressed cell motility and tumorigenesis in vitro and in vivo, which were all rescued by stable ectopic re-expression of wild-type Grb2 but not the mutant Grb2(K56R). Furthermore, Grb2 SUMOylation at K(56) increased the formation of Grb2-Sos1 complex, which sequentially leads to the activation of Ras/MEK/MAPK pathway. CONCLUSIONS: Our results provide evidences that Grb2 is SUMOylated in vivo and this modification enhances ERK activities via increasing the formation of Grb2-Sos1 complex, and may consequently promote cell motility, transformation and tumorigenesis.
format Online
Article
Text
id pubmed-4021559
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40215592014-05-16 SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1 Qu, Yingying Chen, Qin Lai, Xueping Zhu, Changhong Chen, Cheng Zhao, Xian Deng, Rong Xu, Ming Yuan, Haihua Wang, Yanli Yu, Jianxiu Huang, Jian Mol Cancer Research BACKGROUND: Grb2 (Growth factor receptor-bound protein 2) is a key adaptor protein in maintaining the ERK activity via linking Sos1 (Son of sevenless homolog 1) or other proteins to activated RTKs, such as EGFR. Currently, little knowledge is available concerning the post-translational modification (PTM) of Grb2 except for its phosphorylation. Since emerging evidences have highlighted the importance of SUMOylation (Small ubiquitin-related modifier), a reversible PTM, in modulating protein functions, we wondered if Grb2 could be SUMOylated and thereby influences its functions especially involved in the Ras/MEK/ERK pathway. METHODS: SUMOylation of Grb2 was analyzed with the in vivo SUMOylation assay using the Ni(2+)-NTA affinity pulldown and the in vitro E.coli-based SUMOylation assay. To test the ERK activity and cell transformation, the murine fibroblast cell line NIH/3T3 and the murine colon cancer cell line CMT-93 were used for the experiments including Grb2 knockdown, ectopic re-expression, cell transformation and migration. Immunoprecipitation (IP) was employed for seeking proteins that interact with SUMO modified Grb2. Xenograft tumor model in mice was conducted to verify that Grb2 SUMOylation regulated tumorigenesis in vivo. RESULTS: Grb2 can be SUMOylated by SUMO1 at lysine 56 (K(56)), which is located in the linker region between the N-terminal SH3 domain and the SH2 domain. Knockdown of Grb2 reduced the ERK activity and suppressed cell motility and tumorigenesis in vitro and in vivo, which were all rescued by stable ectopic re-expression of wild-type Grb2 but not the mutant Grb2(K56R). Furthermore, Grb2 SUMOylation at K(56) increased the formation of Grb2-Sos1 complex, which sequentially leads to the activation of Ras/MEK/MAPK pathway. CONCLUSIONS: Our results provide evidences that Grb2 is SUMOylated in vivo and this modification enhances ERK activities via increasing the formation of Grb2-Sos1 complex, and may consequently promote cell motility, transformation and tumorigenesis. BioMed Central 2014-04-29 /pmc/articles/PMC4021559/ /pubmed/24775912 http://dx.doi.org/10.1186/1476-4598-13-95 Text en Copyright © 2014 Qu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Qu, Yingying
Chen, Qin
Lai, Xueping
Zhu, Changhong
Chen, Cheng
Zhao, Xian
Deng, Rong
Xu, Ming
Yuan, Haihua
Wang, Yanli
Yu, Jianxiu
Huang, Jian
SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1
title SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1
title_full SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1
title_fullStr SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1
title_full_unstemmed SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1
title_short SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1
title_sort sumoylation of grb2 enhances the erk activity by increasing its binding with sos1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021559/
https://www.ncbi.nlm.nih.gov/pubmed/24775912
http://dx.doi.org/10.1186/1476-4598-13-95
work_keys_str_mv AT quyingying sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT chenqin sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT laixueping sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT zhuchanghong sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT chencheng sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT zhaoxian sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT dengrong sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT xuming sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT yuanhaihua sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT wangyanli sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT yujianxiu sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1
AT huangjian sumoylationofgrb2enhancestheerkactivitybyincreasingitsbindingwithsos1